- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Inefficient Market Opportunities
Global Pharmaceuticals & Biotech Inefficient Market Opportunities
Results
2
0 new
Less coverage brings about more information asymmetry and more opportunities to buy mispriced stocks. Companies valued at less than US$500M with low PE and PEG.
2 companies
Protalix BioTherapeutics
Market Cap: US$133.7m
A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.
PLX
US$1.72
7D
3.6%
1Y
43.3%
Medexus Pharmaceuticals
Market Cap: CA$86.8m
Operates as a pharmaceutical company in Canada and the United States.
MDP
CA$2.58
7D
-0.4%
1Y
59.3%